• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

High-throughput screening assays to discover small-molecule inhibitors of protein interactions.

作者信息

Colas Pierre

机构信息

CNRS UPS 2682, Station Biologique, Place Georges Teissier, 29680 Roscoff, France.

出版信息

Curr Drug Discov Technol. 2008 Sep;5(3):190-9. doi: 10.2174/157016308785739875.

DOI:10.2174/157016308785739875
PMID:18690888
Abstract

The availability of large collections of small-molecule inhibitors of protein interactions would bear a tremendous impact both on academic and therapeutic research. The past recent years have seen a marked acceleration in the discovery of protein interaction inhibitors, through structure-based drug design but mostly through screening efforts. This article attempts to review the impressive number and variety of in vitro and cellular screening assays that have been developed and, for most of them, used successfully to identify small-molecule inhibitors of protein interactions. Various strategies aimed at improving hit rates are also reviewed, and future challenges to improve discovery success rates are discussed. The growing list of protein interaction inhibitors and the large arsenal of screening methods, now available to most laboratories or screening facilities, will probably convince an increasing number of academic and industrial scientists that protein interactions are more druggable than once feared, and that their respective research interests would greatly benefit from the discovery of protein interaction inhibitors.

摘要

相似文献

1
High-throughput screening assays to discover small-molecule inhibitors of protein interactions.
Curr Drug Discov Technol. 2008 Sep;5(3):190-9. doi: 10.2174/157016308785739875.
2
Protein-protein interaction modulator drug discovery: past efforts and future opportunities using a rich source of low- and high-throughput screening assays.蛋白质-蛋白质相互作用调节剂药物发现:利用丰富的低通量和高通量筛选试验的过往努力与未来机遇
Expert Opin Drug Discov. 2014 Dec;9(12):1393-404. doi: 10.1517/17460441.2014.954544. Epub 2014 Nov 6.
3
NMR screening and hit validation in fragment based drug discovery.基于片段的药物发现中的 NMR 筛选和命中验证。
Curr Top Med Chem. 2011;11(1):43-67. doi: 10.2174/156802611793611887.
4
High-Throughput Screening by Nuclear Magnetic Resonance (HTS by NMR) for the Identification of PPIs Antagonists.用于鉴定蛋白质-蛋白质相互作用拮抗剂的核磁共振高通量筛选(基于核磁共振的高通量筛选)
Curr Top Med Chem. 2015;15(20):2032-42. doi: 10.2174/1568026615666150519102459.
5
Affinity-based screening techniques: their impact and benefit to increase the number of high quality leads.基于亲和力的筛选技术:其对增加高质量先导化合物数量的影响和益处。
Expert Opin Drug Discov. 2010 Nov;5(11):1095-107. doi: 10.1517/17460441.2010.524641. Epub 2010 Oct 7.
6
Benchmark Study Based on 2P2I to Gain Insights into the Discovery of Small-Molecule PPI Inhibitors.基于 2P2I 的基准研究,深入了解小分子 PPI 抑制剂的发现。
J Phys Chem B. 2018 Mar 8;122(9):2544-2555. doi: 10.1021/acs.jpcb.7b12658. Epub 2018 Feb 22.
7
Small-molecule inhibitors of protein-protein interactions: how to mimic a protein partner.小分子蛋白-蛋白相互作用抑制剂:如何模拟蛋白伴侣。
Curr Pharm Des. 2012;18(30):4679-84. doi: 10.2174/138161212802651634.
8
Pharmacophore modelling as a virtual screening tool for the discovery of small molecule protein-protein interaction inhibitors.基于药效团模型的小分子蛋白-蛋白相互作用抑制剂虚拟筛选技术研究
Curr Pharm Des. 2012;18(30):4586-98. doi: 10.2174/138161212802651616.
9
High impact technologies for natural products screening.用于天然产物筛选的高影响力技术。
Prog Drug Res. 2008;65:175, 177-210. doi: 10.1007/978-3-7643-8117-2_5.
10
The use of mammalian two-hybrid technologies for high-throughput drug screening.哺乳动物双杂交技术在高通量药物筛选中的应用。
Methods. 2012 Dec;58(4):335-42. doi: 10.1016/j.ymeth.2012.08.003. Epub 2012 Aug 14.

引用本文的文献

1
Characterization of allosteric modulators that disrupt androgen receptor co-activator protein-protein interactions to alter transactivation-Drug leads for metastatic castration resistant prostate cancer.鉴定破坏雄激素受体共激活蛋白-蛋白相互作用从而改变反式激活的变构调节剂-用于转移性去势抵抗性前列腺癌的药物先导物。
SLAS Discov. 2023 Oct;28(7):325-343. doi: 10.1016/j.slasd.2023.08.001. Epub 2023 Aug 6.
2
High Content Positional Biosensor Assay to Screen for Compounds that Prevent or Disrupt Androgen Receptor and Transcription Intermediary Factor 2 Protein-Protein Interactions.用于筛选预防或破坏雄激素受体与转录中介因子2蛋白-蛋白相互作用的化合物的高内涵定位生物传感器分析
Methods Mol Biol. 2018;1683:211-227. doi: 10.1007/978-1-4939-7357-6_13.
3
An in vivo multiplexed small-molecule screening platform.一种体内多重小分子筛选平台。
Nat Methods. 2016 Oct;13(10):883-889. doi: 10.1038/nmeth.3992. Epub 2016 Sep 12.
4
Reconfiguring the AR-TIF2 Protein-Protein Interaction HCS Assay in Prostate Cancer Cells and Characterizing the Hits from a LOPAC Screen.在前列腺癌细胞中重新配置AR-TIF2蛋白质-蛋白质相互作用的高内涵筛选分析,并对LOPAC筛选得到的命中结果进行表征。
Assay Drug Dev Technol. 2016 Oct;14(8):453-477. doi: 10.1089/adt.2016.741. Epub 2016 Sep 8.
5
Bone Regeneration Based on Tissue Engineering Conceptions - A 21st Century Perspective.基于组织工程概念的骨再生 - 21 世纪的展望。
Bone Res. 2013 Sep 25;1(3):216-48. doi: 10.4248/BR201303002. eCollection 2013 Sep.
6
High-content positional biosensor screening assay for compounds to prevent or disrupt androgen receptor and transcriptional intermediary factor 2 protein-protein interactions.用于筛选预防或破坏雄激素受体与转录中介因子2蛋白质-蛋白质相互作用的化合物的高内涵定位生物传感器检测法。
Assay Drug Dev Technol. 2014 Sep;12(7):395-418. doi: 10.1089/adt.2014.594.
7
Four amino acids within a tandem QxVx repeat in a predicted extended α-helix of the Smad-binding domain of Sip1 are necessary for binding to activated Smad proteins.在 Sip1 的 Smad 结合域预测的伸展α螺旋中串联 QxVx 重复的四个氨基酸对于与激活的 Smad 蛋白结合是必需的。
PLoS One. 2013 Oct 11;8(10):e76733. doi: 10.1371/journal.pone.0076733. eCollection 2013.
8
IP-FCM measures physiologic protein-protein interactions modulated by signal transduction and small-molecule drug inhibition.IP-FCM 可测量受信号转导和小分子药物抑制调节的生理蛋白-蛋白相互作用。
PLoS One. 2012;7(9):e45722. doi: 10.1371/journal.pone.0045722. Epub 2012 Sep 21.
9
Cellular cofactors of lentiviral integrase: from target validation to drug discovery.慢病毒整合酶的细胞辅助因子:从靶点验证到药物发现
Mol Biol Int. 2012;2012:863405. doi: 10.1155/2012/863405. Epub 2012 Aug 7.
10
A-kinase anchoring proteins as potential drug targets.A-激酶锚定蛋白作为潜在的药物靶点。
Br J Pharmacol. 2012 May;166(2):420-33. doi: 10.1111/j.1476-5381.2011.01796.x.